Company Search:
Advanced Search
Sponsored Links
Atect Corp Company Snapshot
Atect Corp operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Atect Corp with three other pharmaceutical manufacturers in Asia: Ina Research Incorporation (2017 sales of 2.30 billion Japanese Yen [US$20.64 million] of which 86% was Non-clinical business), Pharma Foods International Co.Ltd (4.72 billion Japanese Yen [US$42.46 million] of which 73% was Functional product(Online business)), and Hester Pharmaceuticals Limited which is based in India (1.23 billion Indian Rupees [US$19.26 million] of which 88% was Poultry Vaccines).

Sales Analysis. Atect Corp reported sales of ¥2.48 billion (US$22.32 million) for the fiscal year ending March of 2017. This represents a very small increase of 0.4% versus 2016, when the company's sales were ¥2.47 billion. The sales level in 2017 was fairly close to the level five years ago: in 2012, Atect Corp had sales of ¥2.50 billion. Sales of Semiconductor Material saw an increase that was more than double the company's growth rate: sales were up 3.5% in 2017, from ¥793.50 million to ¥821.57 million. Not all segments of Atect Corp experienced an increase in sales in 2017: sales of Health Inspection Equipment fell 1.2% to ¥1.56 billion. Atect Corp also experienced decreases in sales in Pim (down 0.6% to ¥105.49 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Atect Corp
  Stock Performance Chart for Atect Corp
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 1,557.00
(Figures in Japanese Yen)
1 Week -0.8%   13 Weeks 1.2%  
4 Weeks -0.8%   52 Weeks 56.0%  
Atect Corp Key Data:
  Ticker: 4241 Country: Japan
  Exchanges: TYO JSQ Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 2,483,147,000
(Year Ending Jan 2018).
Employees: 80
  Currency: Japanese Yen Market Cap: 6,711,917,157
  Fiscal Yr Ends: March Shares Outstanding: 4,310,801
  Share Type: Common Closely Held Shares: 2,397,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.